Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Executive Leadership Team Change 05-Apr-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars 28.02.2023 / 07:00 CET/CEST Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE® Bars P.
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars 28.02.2023 / 07:00
Relief Therapeutics Holding SA / Key word(s): Market LaunchRelief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars 28.02.2023 / 07:00 CET/CESTRelief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE® Bars Paolo Galfetti, chief op.
Relief Therapeutics Holding SA / Key word(s): Miscellaneous APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival